Phase 1 Study of the Combination of Rogaratinib With Copanlisib in Patients With Fibroblast Growth Factor Receptor (FGFR)-Positive, Locally Advanced or Metastatic Solid Tumors
Clinical trial NCT03517956 · COMPLETED
Trial details
- NCT number
- NCT03517956
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-07-25
- Primary completion
- 2021-02-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.